Work

Romiplostim for chemotherapy-induced thrombocytopenia (CIT) in colorectal, gastroesophageal, and pancreatic cancers: A global, phase 3, randomized, placebo-controlled trial (RCT).

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.12007

Authors: Hanny Al-Samkari, Cesar Munoz, Caglayan Geredeli, Ippokratis Korantzis, Beatriz Gonzalez Astorga, Cagatay Arslan, Johnny Francisco Cordeiro Camargo, Florian Scotte, Giuliano Borges, Kejia Wang, Melissa Eisen, David Kuter, Gerald A. Soff

Institutions: Massachusetts General Hospital, HM Hospitales, Istinye University, St. Luke's Hospital, Instituto de Oncologia do Paraná, Institut Gustave Roussy, Fondation Gustave Roussy, Amgen (United States), University of Miami Health System

Language: English

Topic: Platelet Disorders and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Amgen

OpenAlex ID: W4410815289

Cites:

Cited by: 1

Related to: 10